Baycol and Tegretol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 20 people who take Baycol and Tegretol. Common interactions include thrombocytopenia among females, and dyspnoea among males.

The phase IV clinical study analyzes what interactions people who take Baycol and Tegretol have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

What are phase IV trials?

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 24, 2023

20 people who take Baycol and Tegretol together, and have interactions are studied.


What is Baycol?

Baycol has active ingredients of cerivastatin sodium. Currently, eHealthMe is studying from 19,132 Baycol users.

What is Tegretol?

Tegretol has active ingredients of carbamazepine. It is used in epilepsy. Currently, eHealthMe is studying from 45,133 Tegretol users.

Number of Baycol and Tegretol reports submitted per year:

Baycol and Tegretol drug interactions.

Common Baycol and Tegretol drug interactions by gender *:

female:

  1. Thrombocytopenia
  2. Oedema
  3. Oliguria
  4. Paraesthesia
  5. Peripheral neuropathy
  6. Transfusion reaction

male:

  1. Dyspnoea
  2. Peripheral neuropathy
  3. Confusion
  4. Dermatitis
  5. Drug eruption
  6. Lethargy
  7. Pain
  8. Polyneuropathy
  9. Pruritus
  10. Rhabdomyolysis

Common Baycol and Tegretol drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Infection
  2. Myocardial infarction
  3. Polyneuropathy
  4. Simple partial seizures
  5. Vertigo
  6. Weight decreased
  7. Wound dehiscence

50-59:

  1. Aggression
  2. Grand mal convulsion
  3. Confusion
  4. Paraesthesia
  5. Peripheral neuropathy

60+:

  1. Dyspnoea
  2. Peripheral neuropathy
  3. Drug eruption
  4. Lethargy
  5. Pain
  6. Pruritus
  7. Rhabdomyolysis
  8. Transfusion reaction
  9. Muscle weakness
  10. Weakness

* Approximation only. Some reports may have incomplete information.

Do you take Baycol and Tegretol?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Baycol side effects:

Browse all side effects of Baycol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tegretol side effects:

Browse all side effects of Tegretol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Baycol interactions:

Browse all interactions between Baycol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tegretol interactions:

Browse all interactions between Tegretol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cerivastatin sodium and carbamazepine (the active ingredients of Baycol and Tegretol, respectively), and Baycol and Tegretol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Baycol and Tegretol.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: